Benign Prostatic Hyperplasia Pharmacotherapy and Incident Ocular Surface Disease: Comparative Risk of Alpha-blockers vs 5-alpha Reductase Inhibitors

Posted by author-avatar

Publication date: October 2026

Source: Urology, Volume 216

Author(s): Zaid Ahmed, Elia Abou Chawareb, Muhammed A.M. Hammad, Samet Senel, Yara Matar, Jake Miller, Mohammed Shahait, Faysal A. Yafi

Read More

Newer
Reply to Editorial Comment on “Same-day Discharge Following Multiport Robot-assisted Simple Prostatectomy: A Prospective Feasibility Study of Outcomes, Costs, and Post-discharge Healthcare Utilization”
Older Reply to “Editorial Comment on “Gender representation and regional affluence as dual drivers of reimbursement equity in Urology